IDiyas

For the Inventor, By the Inventor

Caldwell, NJ, United States of America

Stuart W McCombie

USPTO Granted Patents = 48


Average Co-Inventor Count = 2.5

ph-index = 14

Forward Citations = 666(Granted Patents)


Location History:

  • East Orange, NJ (US) (1977)
  • West Orange, NJ (US) (1978 - 1987)
  • Caldwell, NJ (US) (1986 - 2012)

Company Filing History:

goldMedal48 out of 1,829 
 
Schering Corporation
 patents

Years Active: 1977-2012

Loading Chart...
Loading Chart...
48 patents (USPTO):Explore Patents
1. 8114879 - Piperazine derivatives useful as CCR5 antagonists (2012-02-14),
2. 7750158 - Cannabinoid receptor ligands (2010-07-06),
3. 7705153 - Bipiperdine derivatives useful as CCR3 antagonists (2010-04-27),
4. 7705019 - Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors (2010-04-27),
5. 7659275 - Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors (2010-02-09),
6. 7384944 - Piperazine derivatives useful as CCR5 antagonists (2008-06-10),
7. 7309704 - Heteroaryl urea neuropeptide Y Y5 receptor antagonists (2007-12-18),
8. 6982267 - Heteroaryl urea neuropeptide Y Y5 receptor antagonists (2006-01-03),
9. 6946476 - Heteroaryl urea neuropeptide Y Y5 receptor antagonists (2005-09-20),
10. 6894063 - Substituted urea neuropeptide Y Y5 Receptor antagonists (2005-05-17),
11. 6689765 - Piperazine derivatives useful as CCR5 antagonists (2004-02-10),
12. 6602885 - Piperidine derivatives useful as CCR5 antagonists (2003-08-05),
13. 6498168 - Muscarinic antagonists (2002-12-24),
14. 6451797 - Muscarinic antagonists (2002-09-17),
15. 6391865 - Piperazine derivatives useful as CCR5 antagonists (2002-05-21),

Title: The Innovative Work of Inventor Stuart W McCombie

Introduction: Stuart W McCombie is a prominent inventor based in Caldwell, NJ, with an impressive portfolio of 48 patents to his name. His groundbreaking contributions in the field of pharmaceuticals have significantly impacted the medical industry.

Latest Patents: McCombie's latest patents include cutting-edge inventions such as Piperazine derivatives useful as CCR5 antagonists and Cannabinoid receptor ligands. These innovations highlight his focus on developing compounds with anti-inflammatory and immunomodulatory properties, offering new treatment possibilities for cancer, inflammatory, immunomodulatory, and respiratory diseases.

Career Highlights: Stuart W McCombie showcases his expertise as an inventor at Schering Corporation, a renowned pharmaceutical company. His dedication to research and development has led to the creation of numerous patented technologies that have the potential to revolutionize the healthcare landscape.

Collaborations: McCombie has collaborated closely with esteemed coworkers Susan F Vice and Jayaram R Tagat. Together, they have worked on innovative projects that have resulted in cutting-edge pharmaceutical solutions.

Conclusion: Stuart W McCombie's trailblazing work as an inventor exemplifies his commitment to advancing healthcare through innovative technologies. His numerous patents and collaborations stand as a testament to his passion for driving positive change in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…